Corticosteroids in the treatment of Sydenham's chorea

L. N. Green

This is a retrospective study of the treatment of eight female patients with Sydenham's chorea by corticosteroid administration. The rationale for use of this medication is based on the concept that Sydenham's chorea is caused by an indolent inflammation of the small vessels in the caudate-putamen complex. All patients in this series responded to corticosteroid treatment relatively rapidly, with considerable diminution in abnormal movements. It is concluded that corticosteroid treatment of this condition is effective and deserves wider use. This report should serve as an impetus for more controlled studies.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sydenham's Chorea: A Clinical Follow-Up of 65 Patients
Demiroren et al.
J Child Neurol 2007;22:550-554.
ABSTRACT  

Are antibasal ganglia antibodies important, and clinically useful?
Martino et al.
PN 2007;7:32-41.
FULL TEXT  

Treatment of Sydenham's Chorea with Intravenous Immunoglobulin, Plasma Exchange, or Prednisone
Garvey et al.
J Child Neurol 2005;20:424-429.
ABSTRACT  

Dyskinesias and associated psychiatric disorders following streptococcal infections
Dale et al.
Arch. Dis. Child. 2004;89:604-610.
ABSTRACT | FULL TEXT  

Dementia-Like Presentation of Striatal Hypermetabolic State With Antistriatal Antibodies Responsive to Steroids
Leger et al.
Arch Neurol 2004;61:754-757.
ABSTRACT | FULL TEXT  

Autoimmunity and the basal ganglia: new insights into old diseases
Dale
QJM 2003;96:183-191.
ABSTRACT | FULL TEXT  

Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea
Church et al.
Neurology 2002;59:227-231.
ABSTRACT | FULL TEXT  

Antineuronal Antibodies in Rheumatic Chorea
Kotby et al.
CVI 1998;5:836-839.
ABSTRACT | FULL TEXT